Mortality of patients who dropped out from regular lithium prophylaxis: A collaborative study by the International Group for the Study of Lithium-Treated Patients (IGSLI)

Acta Psychiatrica Scandinavica

Volumn 94, Issue 5, 1996, Pages 344-347

  Muller Oerlinghausen B ^a   Wolf, T ^a   Ahrens, B ^a   Glaenz, T ^a   Schou, M ^b   Grof, E ^c   Grof, P ^c   Lenz, G ^d   Simhandl, C ^d   Thau, K ^d   Vestergaard, P ^b   Wolf, R ^d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c ROYAL OTTAWA HOSPITAL   (Canada)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Affective disorder; Lithium; Mortality

Indexed keywords

LITHIUM;

ADULT; AFFECTIVE NEUROSIS; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 10544232276     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb09870.x     Document Type: Article

References (21)

1. COPPEN A, STANDISH-BARRY H, BAILEY J, HOUSTON G, SILCOCKS P, HERMON C. Does lithium reduce the mortality of recurrent mood disorders? J Affect Dis 1991: 23: 1-7.
2. MÜLLER-OERLINGHAUSEN B, AHRENS B, VOLK J et al. Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI. Psychiatr Res 1991: 36: 329-331.
3. MÜLLER-OERLINGHAUSEN B, AHRENS B, GROF E et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive or schizo-affective illness. Acta Psychiatr Scand 1992: 86: 218-222.
4. MÜLLER-OERLINGHAUSEN B, MÜSER-CAUSEMANN B, VOLK J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Dis 1992: 25: 261-270.
5. COPPEN A. Depression as a lethal disease: prevention strategies. J Clin Psychiatry 1994: 55 (Suppl. 4): 37-45.
6. FELBER W, KYBER A. Suizide amd Parasuizide während und außerhalb einer Lithiumprophylaxe. In: MüLLER-OERLINGHAUSEN B, BERGHÖFER A, ed. Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart: Thieme, 1994: 53-59.
7. LENZ G, AHRENS A, DENK E et al. Mortalität nach Ausscheiden aus der Lithiumambulanz. In: MÜLLER-OERLINGHAUSEN B, BERGHÖFER A, ed. Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart: Thieme, 1994: 49-52.
8. THIES-FLETCHNER K, MÜLLER-OERLINGHAUSEN B, SEIBERT W, WALTHER A, GREIL W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 1996: 29: 103-107.
9. AHRENS B, MÜLLER-OERLINGHAUSEN B, SCHOU M et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Dis 1995: 33: 67-75.
10. NILSSON A. Mortality in recurrent mood disorders during periods on and off lithium: a complete population study in 362 patients. Pharmacopsychiatry 1995: 28: 8-13.
11. MÜLLER-OERLINGHAUSEN B, WOLF T, AHRENS B et al. Mortality during initial and during later lithium treatment. Acta Psychiatr Scand 1994: 90: 295-297.
12. BRESLOW NE, DAY NE. The standardized mortality ratio. In: SEN PK, ed. Biostatistics: statistics in biomedical, public health and environmental sciences. Amsterdam: Elsevier, 1985: 55-74.
13. WOLF T, MÜLLER-OERLINGHAUSEN B, AHRENS B et al. How to interpret findings on mortality of long-term lithium treated manic-depressive patients? Critique of different methodological approaches. J Affect Dis 1996: 39: 127-132.
14. SCHOU M. Mortality-lowering effect of prophylactic lithium treatment: a look at the evidence. Pharmacopsychiatry 1995: 28: 1.
15. HARROW M, GOLDBERG JF, GROSSMAN LS, MELTZER HY. Outcome of manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry 1990: 47: 665-671.
16. SURTEES PG, BARKLAY C. Future imperfect: the long-term outcome of depression. Br J Psychiatry 1994: 164: 327-341.
17. GOLDBERG JF, HARROW M, GROSSMAN LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 1995: 152: 379-384.
18. SCHOU M, WEEKE A. Did manic-depressive patients who committed suicide receive prophylactic or continuation treatment at the time? Br J Psychiatry 1988: 153: 324-327.
19. ISOMETSÄ E, HENRIKSSON M, LÖNNQVIST J. Completed suicide and recent lithium treatment. J Affect Dis 1992: 26: 101-104.
20. GREIL W, LUDWIG-MAYERHOFER W, ERAZO N et al. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression - a randomized study. J Affect Dis (in press).
21. GREIL W, LUDWIG-MAYERHOFER W, STELLER B et al. Lithium- oder Carbamazepinprophylaxe bei affektiven Psychosen: Ergebnisse einer kontrollierten, multizentrischen Studie. In: MÜLLER-OERLINGHAUSEN B, BERGHÖFER A, ed. Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Stuttgart: Thieme, 1994: 113-119.